Anthropometric models to estimate fat mass at 3 days, 15 and 54 weeks
- PMID: 34558804
- PMCID: PMC8821135
- DOI: 10.1111/ijpo.12855
Anthropometric models to estimate fat mass at 3 days, 15 and 54 weeks
Abstract
Background: Currently available infant body composition measurement methods are impractical for routine clinical use. The study developed anthropometric equations (AEs) to estimate fat mass (FM, kg) during the first year using air displacement plethysmography (PEA POD® Infant Body Composition System) and Infant quantitative magnetic resonance (Infant-QMR) as criterion methods.
Methods: Multi-ethnic full-term infants (n = 191) were measured at 3 days, 15 and 54 weeks. Sex, race/ethnicity, gestational age, age (days), weight-kg (W), length-cm (L), head circumferences-cm (HC), skinfold thicknesses mm [triceps (TRI), thigh (THI), subscapular (SCP), and iliac (IL)], and FM by PEA POD® and Infant-QMR were collected. Stepwise linear regression determined the model that best predicted FM.
Results: Weight, length, head circumference, and skinfolds of triceps, thigh, and subscapular, but not iliac, significantly predicted FM throughout infancy in both the Infant-QMR and PEA POD models. Sex had an interaction effect at 3 days and 15 weeks for both the models. The coefficient of determination [R2 ] and root mean square error were 0.87 (66 g) at 3 days, 0.92 (153 g) at 15 weeks, and 0.82 (278 g) at 54 weeks for the Infant-QMR models; 0.77 (80 g) at 3 days and 0.82 (195 g) at 15 weeks for the PEA POD models respectively.
Conclusions: Both PEA POD and Infant-QMR derived models predict FM using skinfolds, weight, head circumference, and length with acceptable R2 and residual patterns.
Keywords: PEAPOD; body composition; infancy; infant-QMR; pediatrics.
© 2021 World Obesity Federation.
Conflict of interest statement
Figures
References
-
- Fryar CD, Gu Q, Ogden CL, Flegal KM. Anthropometric Reference Data for Children and Adults: United States, 2011–2014. Vital Health Stat 3 Aug 2016;(39):1–46. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK094466/DK/NIDDK NIH HHS/United States
- P2C HD042849/HD/NICHD NIH HHS/United States
- U01 HL114377/HL/NHLBI NIH HHS/United States
- T32 DK065522/DK/NIDDK NIH HHS/United States
- U01 DK094416/DK/NIDDK NIH HHS/United States
- R00 HD086304/HD/NICHD NIH HHS/United States
- UH3 DK128302/DK/NIDDK NIH HHS/United States
- U01 DK094463/DK/NIDDK NIH HHS/United States
- U01 HD072834/HD/NICHD NIH HHS/United States
- T32 DK091227/DK/NIDDK NIH HHS/United States
- P30 DK026687/DK/NIDDK NIH HHS/United States
- U01 HL114344/HL/NHLBI NIH HHS/United States
- K99 HD086304/HD/NICHD NIH HHS/United States
- U01 DK094418/DK/NIDDK NIH HHS/United States
- T32 DK007559/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
